HMG-CoA reductase and P2Y12 receptor — Drug Target

All drugs that target HMG-CoA reductase and P2Y12 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Statin and P2Y12 platelet inhibitor combination

Marketed (1)

• atorvastatin and clopidogrel · Ospedale Misericordia e Dolce · Statin and P2Y12 platelet inhibitor combination · Cardiovascular
  This combination reduces cholesterol levels and prevents blood clots by inhibiting HMG-CoA reductase and platelet aggregation, respectively.